Thus, in study [83], the upregulated lncRNA DLX6-AS1 promotes RCC progression via the DLX6-AS1/miR-26a/PTEN axis, although the phosphatase and tensin homolog (PTEN) gene is known as a classical tumor suppressor, including RCC [84]. The gene discussed is DLX6; the disease is renal cell carcinoma.